Abstract: The present invention relates to an extended release formulation of macrolide antibiotic. More particularly, the present invention relates to an extended release formulation of erythromycin derivatives. The present invention also relates to a process for the preparation of extended release formulation containing erythromycin derivatives.
| # | Name | Date |
|---|---|---|
| 1 | 0584-che-2007-correspondnece-others.pdf | 2011-09-03 |
| 1 | 0584-che-2007-form 1.pdf | 2011-09-03 |
| 2 | 0584-che-2007-description(provisional).pdf | 2011-09-03 |
| 3 | 0584-che-2007-correspondnece-others.pdf | 2011-09-03 |
| 3 | 0584-che-2007-form 1.pdf | 2011-09-03 |